Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs

Recruiting now · Phase 2

Conditions studied: Hepatocellular Carcinoma, Solid Tumor, Adult

In brief

To study the safety and clinical effect of injection of drug-eluting microspheres with multiple chemodrug and/or protein drugs into advanced solid tumors.

Key facts

Study ID

NCT04770207

Run by

Second Affiliated Hospital of Guangzhou Medical University

People needed

100

Starts

2020-11-01

Expected to finish

2035-11-01

Last updated by the study team

2024-08-21

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Solid advanced malignant tumors
• Age between18 and 99 years
• Life expectancy is greater than three months

You may not qualify if…

• Benign tumor
• Life expectancy is less than three months
• Serious medical comorbidity
• Others

Where it is running

• The Second Affiliated Hospital of Guangzhou Medical University — Guangzhou, Guangdong, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.